These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 27738124

  • 21. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A.
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [Abstract] [Full Text] [Related]

  • 22. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.
    Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB.
    J Urol; 2001 Oct; 166(4):1487-91. PubMed ID: 11547118
    [Abstract] [Full Text] [Related]

  • 23. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S, Knight J, Assimos DG, Holmes RP.
    J Urol; 2007 Nov; 178(5):2186-90. PubMed ID: 17870112
    [Abstract] [Full Text] [Related]

  • 24. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL.
    ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul 06; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS.
    Chamberlain CA, Hatch M, Garrett TJ.
    Anal Bioanal Chem; 2019 Jul 06; 411(19):4807-4818. PubMed ID: 30740635
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
    Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, Ben Hmida M, De S, Hunley TE, Jarraya F, Fraga G, Banos A, Lindner E, Dehmel B, Schalk G.
    Pediatr Nephrol; 2023 Feb 06; 38(2):403-415. PubMed ID: 35552824
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease.
    Knight J, Deora R, Assimos DG, Holmes RP.
    Urolithiasis; 2013 Jun 06; 41(3):187-96. PubMed ID: 23632911
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.